Europe Lung Cancer Surgery Market - Industry Trends and Forecast to 2029

Description

List of Tables

Europe lung cancer surgery market is projected to register a substantial CAGR of 5.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:

Europe Lung Cancer Surgery Market, By Product Type (Surgical Instruments, Monitoring & Visualising systems Endosurgical Equipment, Robotic-Assisted Thoracic Surgery Systems and Others), Surgical Procedure (Thoracotomy, Minimally Invasive Surgeries and others), Patient Type (Male and Female), End user, (Hospitals ,Ambulatory Surgical Centers, Academic & Research Laboratories , Specialty Cancer Care Centers and Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales and Others) Country ,(Germany, France, U.K., Italy, Spain, Russia, Turkey, Switzerland, Netherlands, Belgium, Ireland, and Rest of the Europe) Industry Trends & Forecast to 2029.

Some of the major factors contributing to the growth of the Europe lung cancer surgery market are:

Increased prevalence of lung cancer disease
Technological advancements in the field of healthcare
Increased awareness regarding the benefits.
Rise in air pollution and surge in smoking

Market Players:

The key market players for Europe lung cancer surgery market are listed below:

AngioDynamics
Ackermann,
Olympus Corporation
Johnson & Johnson Services, Inc
Ambu A/S.
FUJIFILM Holdings Corporation
Accuray Incorporated
Teleflex Incorporated,
KARL STORZ SE & Co. KG,
TROKAMED GmbH
Others

1 INTRODUCTION 17

1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 OVERVIEW OF THE EUROPE LUNG CANCER SURGERY MARKET 17
1.4 LIMITATIONS 19
1.5 MARKETS COVERED 19

2 MARKET SEGMENTATION 23

2.1 MARKETS COVERED 23
2.2 GEOGRAPHIC SCOPE 24
2.3 YEARS CONSIDERED FOR THE STUDY 25
2.4 CURRENCY AND PRICING 25
2.5 DBMR TRIPOD DATA VALIDATION MODEL 26
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
2.7 MULTIVARIATE MODELLING 30
2.8 PRODUCT TYPE LIFELINE CURVE 30
2.9 DBMR MARKET POSITION GRID 31
2.10 VENDOR SHARE ANALYSIS 33
2.11 MARKET APPLICATION COVERAGE GRID 34
2.12 SECONDARY SOURCES 35
2.13 ASSUMPTIONS 35

3 EXECUTIVE SUMMARY 36

4 PREMIUM INSIGHTS 39

4.1 PESTEL 40
4.2 PORTER'S FIVE FORCES MODEL 41

5 EPIDEMIOLOGY 42

5.1 INCIDENCE OF LUNG CANCER, BY COUNTRY 44
5.2 TREATMENT RATE BY GENDER 45
5.3 MORTALITY BY GENDER 46

6 REGULATIONS OF THE EUROPE LUNG CANCER SURGERY MARKET 47

7 MARKET OVERVIEW 50

7.1 DRIVERS 52
- 7.1.1 INCREASED PREVALENCE OF LUNG CANCER DISEASES 52
- 7.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE 52
- 7.1.3 INCREASED AWARENESS REGARDING THE BENEFITS 52
- 7.1.4 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES 53
- 7.1.5 RISE IN AIR POLLUTION AND SURGE IN SMOKING 53
7.2 RESTRAINTS 54
- 7.2.1 HIGH COST OF LUNG CANCER SURGERY 54
- 7.2.2 INSUFFICIENT FUNDING FOR CANCER AND ASSOCIATED DISORDERS 54
- 7.2.3 STRINGENT REGULATORY FRAMEWORKS 54
7.3 OPPORTUNITIES 56
- 7.3.1 RISE OF MINIMALLY INVASIVE TECHNIQUES IN LUNG CANCER SURGERY 56
- 7.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS 56
- 7.3.3 INCREASE IN RESEARCH AND DEVELOPMENT EFFORTS IN THE HEALTHCARE INDUSTRY 57
7.4 CHALLENGES 57
- 7.4.1 DEARTH OF SKILLED ONCOLOGISTS 57
- 7.4.2 HEALTH RISK OF LUNG CANCER SURGERIES 57

8 EUROPE LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE 59

8.1 OVERVIEW 60
8.2 SURGICAL INSTRUMENTS 63
- 8.2.1 HAND INSTRUMENTS 64
  - 8.2.1.1 STAPLER 65
  - 8.2.1.2 FORCEPS 65
  - 8.2.1.3 ELECTRIC HOOK 65
  - 8.2.1.4 RETRACTORS 65
  - 8.2.1.5 CLAMPS 65
  - 8.2.1.6 SCISSORS 65
  - 8.2.1.7 ELEVATORS 65
  - 8.2.1.8 HEMOCLIP APPLIERS 66
  - 8.2.1.9 ULTRASOUND SCALPEL 66
  - 8.2.1.10 RIB SHEARS 66
  - 8.2.1.11 CUTTERS 66
  - 8.2.1.12 NEEDLE HOLDER 66
  - 8.2.1.13 TROCAR 66
  - 8.2.1.14 OTHERS 66
- 8.2.2 POWERED SURGICAL EQUIPMENT 66
  - 8.2.2.1 ADVANCED ENERGY INSTRUMENTS 67
    - 8.2.2.1.1 ADVANCED BIPOLAR INSTRUMENTS 67
    - 8.2.2.1.2 OTHERS 67
  - 8.2.2.2 BASIC ENERGY INSTRUMENTS 67
    - 8.2.2.2.1 BIPOLAR INSTRUMENTS 68
    - 8.2.2.2.2 MONOPOLAR INSTRUMENTS 68
8.3 MONITORING & VISUALISING SYSTEM 68
- 8.3.1 CAMERAS & VIDEO SUPPORT 69
- 8.3.2 BRONCHOSCOPES 69
- 8.3.3 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS 69
- 8.3.4 THORACOSCOPES 69
- 8.3.5 MEDIASTINOSCOPES 70
- 8.3.6 OTHERS 70
8.4 ENDOSURGICAL EQUIPMENTS 70
8.5 ROBOTIC ASSISTED SURGERY SYSTEMS 71
8.6 OTHERS 71

9 EUROPE LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE 72

9.1 OVERVIEW 73
9.2 THORACOTOMY 76
- 9.2.1 LOBECTOMY 77
  - 9.2.1.1 SURGICAL INSTRUMENTS 77
  - 9.2.1.2 MONITORING & VISUALISING SYSTEMS 77
  - 9.2.1.3 ENDOSURGICAL EQUIPMENT 77
  - 9.2.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 77
  - 9.2.1.5 OTHERS 77
- 9.2.2 SLEEVE RESECTION 78
  - 9.2.2.1 SURGICAL INSTRUMENTS 78
  - 9.2.2.2 MONITORING & VISUALISING SYSTEMS 78
  - 9.2.2.3 ENDOSURGICAL EQUIPMENT 78
  - 9.2.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 78
  - 9.2.2.5 OTHERS 78
- 9.2.3 SEGMENTECTOMY 79
  - 9.2.3.1 SURGICAL INSTRUMENTS 79
  - 9.2.3.2 MONITORING & VISUALISING SYSTEMS 79
  - 9.2.3.3 ENDOSURGICAL EQUIPMENT 79
  - 9.2.3.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 79
  - 9.2.3.5 OTHERS 79
- 9.2.4 PNEUMONECTOMY 80
  - 9.2.4.1 SURGICAL INSTRUMENTS 80
  - 9.2.4.2 MONITORING & VISUALISING SYSTEMS 80
  - 9.2.4.3 ENDOSURGICAL EQUIPMENT 80
  - 9.2.4.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 80
  - 9.2.4.5 OTHERS 80
- 9.2.5 OTHERS 81
9.3 MINIMALLY INVASIVE SURGERIES 81
- 9.3.1 VIDEO-ASSISTED THORACIC SURGERY (VATS) 81
  - 9.3.1.1 SURGICAL INSTRUMENTS 82
  - 9.3.1.2 MONITORING & VISUALISING SYSTEMS 82
  - 9.3.1.3 ENDOSURGICAL EQUIPMENT 82
  - 9.3.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 82
  - 9.3.1.5 OTHERS 82
- 9.3.2 ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS) 82
  - 9.3.2.1 SURGICAL INSTRUMENTS 83
  - 9.3.2.2 MONITORING & VISUALISING SYSTEMS 83
  - 9.3.2.3 ENDOSURGICAL EQUIPMENT 83
  - 9.3.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS 83
  - 9.3.2.5 OTHERS 83

10 EUROPE LUNG CANCER SURGERY MARKET, BY PATIENT TYPE 84

10.1 OVERVIEW 85
10.2 MALE 88
- 10.2.1 GERIATRIC 89
  - 10.2.1.1 THORACOTOMY 89
  - 10.2.1.2 MINIMALLY INVASIVE SURGERIES 89
- 10.2.2 ADULTS 89
  - 10.2.2.1 THORACOTOMY 90
  - 10.2.2.2 MINIMALLY INVASIVE SURGERIES 90
- 10.2.3 PEDIATRIC 90
  - 10.2.3.1 THORACOTOMY 90
  - 10.2.3.2 MINIMALLY INVASIVE SURGERIES 90
10.3 FEMALE 91
- 10.3.1 GERIATRIC 92
  - 10.3.1.1 THORACOTOMY 92
  - 10.3.1.2 MINIMALLY INVASIVE SURGERIES 92
- 10.3.2 ADULTS 92
  - 10.3.2.1 THORACOTOMY 93
  - 10.3.2.2 MINIMALLY INVASIVE SURGERIES 93
- 10.3.3 PEDIATRIC 93
  - 10.3.3.1 THORACOTOMY 93
  - 10.3.3.2 MINIMALLY INVASIVE SURGERIES 93

11 EUROPE LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL 94

11.1 OVERVIEW 95
11.2 DIRECT TENDER 98
11.3 RETAIL SALES 98
11.4 ONLINE SALES 99
11.5 OTHERS 99

12 EUROPE LUNG CANCER SURGERY MARKET, BY END USER 100

12.1 OVERVIEW 101
12.2 HOSPITALS 104
- 12.2.1 PUBLIC HOSPITALS 104
- 12.2.2 PRIVATE HOSPITALS 104
12.3 AMBULATORY SURGICAL CENTERS 105
12.4 SPECIALTY CANCER CARE CENTERS 105
12.5 ACADEMIC AND RESEARCH LABORATORIES 106
12.6 OTHERS 106

13 EUROPE LUNG CANCER SURGERY MARKET, BY REGION 107

13.1 EUROPE 108
- 13.1.1 GERMANY 112
- 13.1.2 FRANCE 112
- 13.1.3 U.K. 112
- 13.1.4 ITALY 112
- 13.1.5 SPAIN 112
- 13.1.6 RUSSIA 112
- 13.1.7 TURKEY 112
- 13.1.8 BELGIUM 113
- 13.1.9 NETHERLANDS 113
- 13.1.10 SWITZERLAND 113
- 13.1.11 REST OF EUROPE 113

14 EUROPE LUNG CANCER SURGERY MARKET: COMPANY LANDSCAPE 114

14.1 COMPANY SHARE ANALYSIS: EUROPE 114

15 SWOT ANALYSIS 115

16 COMPANY PROFILES 116

16.1 JOHNSON & JOHNSON SERVICES, INC. 116
- 16.1.1 COMPANY SNAPSHOT 116
- 16.1.2 REVENUE ANALYSIS 116
- 16.1.3 COMPANY SHARE ANALYSIS 117
- 16.1.4 PRODUCT PORTFOLIO 117
- 16.1.5 RECENT DEVELOPMENTS 117
16.2 ACCURAY INCORPORATED 119
- 16.2.1 COMPANY SNAPSHOT 119
- 16.2.2 REVENUE ANALYSIS 119
- 16.2.3 COMPANY SHARE ANALYSIS 120
- 16.2.4 PRODUCT PORTFOLIO 120
- 16.2.5 RECENT DEVELOPMENTS 120
16.3 INTUITIVE SURGICAL 121
- 16.3.1 COMPANY SNAPSHOT 121
- 16.3.2 REVENUE ANALYSIS 121
- 16.3.3 COMPANY SHARE ANALYSIS 122
- 16.3.4 PRODUCT PORTFOLIO 122
- 16.3.5 RECENT DEVELOPMENTS 122
16.4 FUJIFILM HOLDINGS CORPORATION 123
- 16.4.1 COMPANY SNAPSHOT 123
- 16.4.2 REVENUE ANALYSIS 123
- 16.4.3 COMPANY SHARE ANALYSIS 124
- 16.4.4 PRODUCT PORTFOLIO 124
- 16.4.5 RECENT DEVELOPMENTS 124
16.5 AMBU A/S. 126
- 16.5.1 COMPANY SNAPSHOT 126
- 16.5.2 REVENUE ANALYSIS 126
- 16.5.3 COMPANY SHARE ANALYSIS 127
- 16.5.4 PRODUCT PORTFOLIO 127
- 16.5.5 RECENT DEVELOPMENTS 127
16.6 ANGIODYNAMICS 128
- 16.6.1 COMPANY SNAPSHOT 128
- 16.6.2 REVENUE ANALYSIS 128
- 16.6.3 PRODUCT PORTFOLIO 129
- 16.6.4 RECENT DEVELOPMENT 129
16.7 ACKERMANN 130
- 16.7.1 COMPANY SNAPSHOT 130
- 16.7.2 PRODUCT PORTFOLIO 130
- 16.7.3 RECENT DEVELOPMENTS 130
16.8 ASAP ENDOSCOPIC PRODUCTS GMBH 131
- 16.8.1 COMPANY SNAPSHOT 131
- 16.8.2 PRODUCTPORTFOLIO 131
- 16.8.3 RECENT DEVELOPMENT 131
16.9 FUSIONKRAFT 132
- 16.9.1 COMPANY SNAPSHOT 132
- 16.9.2 PRODUCT PORTFOLIO 132
- 16.9.3 RECENT DEVELOPMENTS 132
16.10 GERMED USA 133
- 16.10.1 COMPANY SNAPSHOT 133
- 16.10.2 PRODUCT PORTFOLIO 133
- 16.10.3 RECENT DEVELOPMENTS 133
16.11 KLS MARTIN GROUP 134
- 16.11.1 COMPANY SNAPSHOT 134
- 16.11.2 PRODUCT PORTFOLIO 134
- 16.11.3 RECENT DEVELOPMENTS 134
16.12 KARL STORZ SE & CO. KG 135
- 16.12.1 COMPANY SNAPSHOT 135
- 16.12.2 PRODUCT PORTFOLIO 135
- 16.12.3 RECENT DEVELOPMENT 135
16.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 136
- 16.13.1 COMPANY SNAPSHOT 136
- 16.13.2 PRODUCT PORTFOLIO 136
- 16.13.3 RECENT DEVELOPMENT 137
16.14 MEDTRONICS (2021) 138
- 16.14.1 COMPANY SNAPSHOT 138
- 16.14.2 REVENUE ANALYSIS 138
- 16.14.3 PRODUCT PORTFOLIO 139
- 16.14.4 RECENT DEVELOPMENT 139
16.15 OLYMPUS CORPORATION 140
- 16.15.1 COMPANY SNAPSHOT 140
- 16.15.2 REVENUE ANALYSIS 140
- 16.15.3 PRODUCTPORTFOLIO 141
- 16.15.4 RECENT DEVELOPMENTS 141
16.16 RICHARD WOLF GMBH. 142
- 16.16.1 COMPANY SNAPSHOT 142
- 16.16.2 PRODUCT PORTFOLIO 142
- 16.16.3 RECENT DEVELOPMENTS 142
16.17 SURGICAL HOLDINGS 143
- 16.17.1 COMPANY SNAPSHOT 143
- 16.17.2 PRODUCT PORTFOLIO 143
- 16.17.3 RECENT DEVELOPMENTS 143
16.18 SONTEC INSTRUMENTS, INC. 144
- 16.18.1 COMPANY SNAPSHOT 144
- 16.18.2 PRODUCT PORTFOLIO 144
- 16.18.3 RECENT DEVELOPMENT 144
16.19 SCANLAN INTERNATIONAL 145
- 16.19.1 COMPANY SNAPSHOT 145
- 16.19.2 PRODUCT PORTFOLIO 145
- 16.19.3 RECENT DEVELOPMENTS 145
16.20 TELEFLEX INCORPORATED 146
- 16.20.1 COMPANY SNAPSHOT 146
- 16.20.2 REVENUE ANALYSIS 146
- 16.20.3 PRODUCTPORTFOLIO 147
- 16.20.4 RECENT DEVELOPMENT 147
16.21 TROKAMED GMBH. 148
- 16.21.1 COMPANY SNAPSHOT 148
- 16.21.2 PRODUCT PORTFOLIO 148
- 16.21.3 RECENT DEVELOPMENT 148
16.22 WEXLER SURGICAL 149
- 16.22.1 COMPANY SNAPSHOT 149
- 16.22.2 PRODUCT PORTFOLIO 149
- 16.22.3 RECENT DEVELOPMENTS 149

17 QUESTIONNAIRE 150

18 RELATED REPORTS 154

LIST OF FIGURES

FIGURE 1 EUROPE LUNG CANCER SURGERYMARKET: SEGMENTATION 22
FIGURE 2 EUROPE LUNG CANCER SURGERY MARKET: GEOGRAPHIC SCOPE 23
FIGURE 3 EUROPE LUNG CANCER SURGERYMARKET: DATA TRIANGULATION 25
FIGURE 4 EUROPE LUNG CANCER SURGERY MARKET: SNAPSHOT 26
FIGURE 5 EUROPE LUNG CANCER SURGERY MARKET: BOTTOM UP APPROACH 27
FIGURE 6 EUROPE LUNG CANCER SURGERY MARKET: TOP DOWN APPROACH 27
FIGURE 7 EUROPE LUNG CANCER SURGERY MARKET: INTERVIEWS BY REGION AND DESIGNATION 28
FIGURE 8 EUROPE LUNG CANCER SURGERY MARKET: DBMR MARKET POSITION GRID 30
FIGURE 9 EUROPE LUNG CANCER SURGERY MARKET: VENDOR SHARE ANALYSIS 32
FIGURE 10 EUROPE LUNG CANCER SURGERY MARKET: END USER COVERAGE GRID 33
FIGURE 11 EUROPE LUNG CANCER SURGERY MARKET SEGMENTATION 37
FIGURE 12 GROWING PREVALENCE OF CANCER DISEASES, RISE IN AIR POLLUTION, AND SURGE IN SMOKING HABIT IS EXPECTED TO DRIVE THE EUROPE LUNG CANCER SURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029 38
FIGURE 13 SURGICAL INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE LUNG CANCER SURGERY MARKET IN 2022 & 2029 38
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE LUNG CANCER SURGERY MARKET 50
FIGURE 15 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2021 59
FIGURE 16 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION) 60
FIGURE 17 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029) 60
FIGURE 18 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE 61
FIGURE 19 EUROPE LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2021 72
FIGURE 20 EUROPE LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2022-2029 (USD MILLION) 73
FIGURE 21 EUROPE LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, CAGR (2022-2029) 73
FIGURE 22 EUROPE LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, LIFELINE CURVE 74
FIGURE 23 EUROPE LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2021 84
FIGURE 24 EUROPE LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION) 85
FIGURE 25 EUROPE LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, CAGR (2022-2029) 85
FIGURE 26 EUROPE LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, LIFELINE CURVE 86
FIGURE 27 EUROPE LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021 94
FIGURE 28 EUROPE LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 95
FIGURE 29 EUROPE LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 95
FIGURE 30 EUROPE LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 96
FIGURE 31 EUROPE LUNG CANCER SURGERY MARKET: BY END USER, 2021 100
FIGURE 32 EUROPE LUNG CANCER SURGERY MARKET: BY END USER, 2022-2029 (USD MILLION) 101
FIGURE 33 EUROPE LUNG CANCER SURGERY MARKET: BY END USER, CAGR (2022-2029) 101
FIGURE 34 EUROPE LUNG CANCER SURGERY MARKET: BY END USER, LIFELINE CURVE 102
FIGURE 35 EUROPE LUNG CANCER SURGERY MARKET: SNAPSHOT (2021) 108
FIGURE 36 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021) 109
FIGURE 37 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029) 109
FIGURE 38 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029) 110
FIGURE 39 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029) 110
FIGURE 40 EUROPE LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%) 113